CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 78 filers reported holding CUE BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,001 | -92.9% | 1,918 | -77.9% | 0.00% | -100.0% |
| Q4 2021 | $98,114 | -25.8% | 8,675 | -4.4% | 0.00% | -50.0% |
| Q3 2021 | $132,237 | +29.4% | 9,076 | +3.4% | 0.00% | +100.0% |
| Q2 2021 | $102,229 | +9.6% | 8,775 | +14.8% | 0.00% | 0.0% |
| Q1 2021 | $93,281 | -15.8% | 7,646 | -13.7% | 0.00% | -50.0% |
| Q4 2020 | $110,776 | -16.9% | 8,855 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $133,268 | -38.6% | 8,855 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $217,036 | +113.8% | 8,855 | +23.8% | 0.00% | +100.0% |
| Q1 2020 | $101,529 | -10.6% | 7,155 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $113,586 | – | 7,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 820,000 | $11,636,000 | 12.56% |
| Prosight Management, LP | 552,060 | $7,834,000 | 3.66% |
| Nantahala Capital Management | 2,503,840 | $35,529,000 | 1.33% |
| MANGROVE PARTNERS IM, LLC | 601,398 | $8,534,000 | 1.18% |
| Voss Capital, LLC | 88,670 | $749,000 | 1.00% |
| Slate Path Capital LP | 870,694 | $12,355,000 | 0.95% |
| Avoro Capital Advisors LLC | 1,870,000 | $26,535,000 | 0.90% |
| Bleichroeder LP | 165,000 | $2,341,000 | 0.61% |
| 683 Capital Management, LLC | 640,000 | $9,082,000 | 0.54% |
| PA Capital LLC | 40,706 | $578,000 | 0.51% |